This page tracks new and upcoming treatment options for Sjogren’s syndrome (SS). What’s in development? What’s promising? What’s available soon? Current topics include CP-25, CFZ533, VAY736, JAK inhibitors, RSLV-132, nuclease therapy, tofacitinib, LOU064, LO2A, anti-CD40 antibodies, AT-RvD1, fecal microbial transplant (FMT), RC-18, iguratimod, stem cells, BMP inhibitors, ustekinumab, AQP5, SS-1, and more.
Last updated: Subscribe